“Innovation Criteria” Could Help Focus Health Spending, J&J Exec Suggests
Policymakers should attempt to define "innovation criteria" to help guide health care resources toward more significant technological advances, Johnson & Johnson Biopharmaceuticals Group Chairman Joseph Scodari told the Wharton Health Care Business Conference Feb. 19 in Philadelphia
You may also be interested in...
Johnson & Johnson is moving towards a business model focused on offering "product solutions" for the health care system, Biopharmaceuticals Group Chairman Joseph Scodari told the Wharton Health Care Business Conference Feb. 19 in Philadelphia
The Centers for Medicare & Medicaid Services has the authority to enforce its position that Amgen's Aranesp is "functionally equivalent" to J&J's Procrit for reimbursement purposes, a D.C. federal appeals court ruled
The appropriate timing for outcomes research is after a product is approved for commercial marketing, FDA Commissioner McClellan told a recent conference on outcomes research sponsored by Merck and AARP